Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:
|
|
26 March 2025
| Name: | VIRALYTICS LIMITED (VLA) | |||||||||
| Date of Listing: | 15 October 1986 | |||||||||
| Date of Delisting: | 21 June 2018 | |||||||||
| Former Names: |
|
Stock Exchange Status:
This entity was delisted from the Australian Securities Exchange on 21 June 2018.Legal Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. We have not therefore verified the current legal status of this entity. If you have questions about your shareholding, as we say elsewhere, they may be taken up here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.Capital Gains Tax (CGT) Status:
To our knowledge this entity was the subject of a takeover or merger such that your securities were acquired for consideration in the form of cash or scrip. You will need to seek independent tax advice in relation to Capital Gains Tax or other tax matters but any other enquiries relating to your shareholding in the company should be followed up via our online form here: https://www.delisted.com.au/TraceLostSharesLostMoney/index/.
Updates, corrections, disagreements please email to admin@delisted.com.au
Further information: deListed and InvestoGain are operated by Investogain Pty Limited which is licensed by ASIC as an Australian Financial Services Licensee (AFSL 334036). deListed acquires only securities that it deems to be of little or no value, in circumstances where the holder is unable to sell their securities on-market in the normal manner. This service has been provided online via the company’s website www.delisted.com.au since 2004.
Getting advice: Information provided in this section is of a general nature and applicable only to Australian tax residents who hold their investments on capital account (ie for long-term investment purposes). It has been prepared without taking into account your financial needs or tax situation. Before acting on the information, deListed suggests that you consider whether it is appropriate for your circumstances and recommends that you seek independent legal, financial, or taxation advice.
Disclaimer: The information provided above is to the best of our knowledge accurate as of today. But you should bear in mind that it is of a general nature and does not constitute financial or tax advice. Investogain Pty Limited accepts no liability for any loss arising from reliance on this information, including reliance on information that is no longer current.
| Company | FROM | TO |
|---|---|---|
| VIRALYTICS LIMITED | 28/12/2006 | |
| PSIRON LIMITED | 17/08/2000 | 28/12/2006 |
| MEDICAL INNOVATIONS LIMITED | 17/08/2000 |
REGISTRY:
Link Market Services Brisbane
Level 21, 10 Eagle Street
Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail
delisted from the close of trading on Thursday 21 June 2018 pursuant to Listing rule 17.11. | 21/06/2018 |
we understand Merck Sharp & Dohme was successful with a cash offer of $1.75 per VLA share | 21/06/2018 |
The scheme of arrangement between its shareholders and Merck Sharp & Dohme was approved by shareholders on 28 May 2018, and by the Federal Court of Australia on 4 June 2018 was implemented today. Viralytics is now 100% owned by MSD. | 20/06/2018 |
The securities of Viralytics Limited will be suspended from quotation at the close of trading today, Tuesday, 5 June 2018 in accordance with Listing Rule 17.2, following lodgement with the Australian Securities and Investments Commission of the orders of the Federal Court of Australia approving the scheme of arrangement by which Merck Sharp & Dohme Pty Ltd will acquire all of the issued shares in the Company. | 05/06/2018 |
a General Meeting is to be held at 11:00am on Thursday, 6 March 2014, at offices of McCullough Robertson, Level 15, 55 Hunter St, Sydney | 04/02/2014 |
The suspension of trading in the securities of Viralytics Limited will be lifted immediately, following receipt of an announcement regarding a capital raising | 22/11/2012 |
The securities of Viralytics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the outcome of a capital raising. Security Code: VLA | 21/11/2012 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 10/08/2011 |
name changed from Psiron Limited | 28/12/2006 |
delisted from the close of trading on Thursday 21 June 2018 pursuant to Listing rule 17.11. | 21/06/2018 |
we understand Merck Sharp & Dohme was successful with a cash offer of $1.75 per VLA share | 21/06/2018 |
The scheme of arrangement between its shareholders and Merck Sharp & Dohme was approved by shareholders on 28 May 2018, and by the Federal Court of Australia on 4 June 2018 was implemented today. Viralytics is now 100% owned by MSD. | 20/06/2018 |
The securities of Viralytics Limited will be suspended from quotation at the close of trading today, Tuesday, 5 June 2018 in accordance with Listing Rule 17.2, following lodgement with the Australian Securities and Investments Commission of the orders of the Federal Court of Australia approving the scheme of arrangement by which Merck Sharp & Dohme Pty Ltd will acquire all of the issued shares in the Company. | 05/06/2018 |
a General Meeting is to be held at 11:00am on Thursday, 6 March 2014, at offices of McCullough Robertson, Level 15, 55 Hunter St, Sydney | 04/02/2014 |
The suspension of trading in the securities of Viralytics Limited will be lifted immediately, following receipt of an announcement regarding a capital raising | 22/11/2012 |
The securities of Viralytics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the outcome of a capital raising. Security Code: VLA | 21/11/2012 |
we understand that on or about this date the company consolidated its shares 1 for 10 | 10/08/2011 |
name changed from Psiron Limited | 28/12/2006 |
Your browser may reflect a date of printing in American format.
Purchases Sales
| DATE | DIRECTOR | NATURE | NUMBER | PRICE | AMOUNT |
|---|---|---|---|---|---|
| 01/12/2016 | Paul Hopper | 10,000 | $1.155 | $11,550 | |
| 21/11/2016 | Paul Hopper | 5,000 | $1.195 | $5,975 | |
| 15/11/2016 | Paul Hopper | 5,000 | $1.275 | $6,375 | |
| 06/05/2016 | Paul Hopper | On market | 6,000 | $0.800 | $4,800 |
| 02/12/2014 | Peter Turvey | On market | 77,274 | $0.320 | $24,728 |
| NAME | TITLE | DATE OF APPT |
|---|---|---|
| Malcolm McColl | Managing Director, CEO | 14/11/2012 |
| Robert Vickery | CFO | 21/05/2013 |
| Riad El-Dada | Director | 20/06/2018 |
| Paul Dodd | Director | 20/06/2018 |
| Georgina Diab | Company Secretary |
Date of first appointment, title may have changed.
| NAME | TITLE | DATE OF APPOINTMENT | DATE OF RESIGNATION |
|---|---|---|---|
| Paul Hopper | Executive Chairman, Independent Director | 04/09/2008 | 20/06/2018 |
| Leonard Post | Non Exec Director | 21/11/2011 | 20/06/2018 |
| Peter Turvey | Non Exec Director | 08/09/2014 | 20/06/2018 |
| Peter Molloy | Non Exec Director | 29/09/2008 | 08/09/2014 |
| Phillip Altman | Non Exec Director | 12/07/2007 | 08/09/2014 |
| Bryan Dulhunty | Managing Director, CEO | 10/04/2006 | 24/07/2012 |
Date of first appointment, title may have changed.
Contact Us | Financial Services Guide | Privacy Policy
This website is owned and operated by Investogain Pty Limited.
ABN 88 129 443 447 | AFSL 334036
Information provided is of a general nature and not for trading or advice.
Copyright © 2002-2025 Investogain Pty Limited. All rights reserved.
